MWNA
SYRS

Marshall Wace North America’s Syros Pharmaceuticals, Inc. Common Stock SYRS Stock Holding History

Marshall Wace North America’s Portfolio SYRS Stock Details SYRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-3,651
Closed -$373K – 1444
2018
Q2 		$373K Buy
+3,651
New +$373K ﹤0.01% 1137
2017
Q4 		– Sell
-1,725
Closed -$259K – 1657
2017
Q3 		$259K Buy
+1,725
New +$259K ﹤0.01% 1150